NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000001896

Registered date:18/04/2009

The clinical significance of circulating tumor cell in metastatic Non-Small Cell Lung Cancer

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedmetastatic non-small cell lung cancer
Date of first enrollment2009/08/01
Target sample size160
Countries of recruitmentJapan
Study typeObservational
Intervention(s)

Outcome(s)

Primary OutcomeTo clarify the relation between CTC and tumor response.
Secondary OutcomeTo clarify the relation between CTC and progression-free survival or overall survival.

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximumNot applicable
GenderMale and Female
Include criteria
Exclude criteria1) chemotherapy including amurubicin 2) Uncontrolled pleural effusion 3) symptomatic brain metastases 4) active concomitant malignancy 5) serious concurrent illness, such as hypertension, angina pectoris, myocardial infarction, or severe infection 6) pregnant/lactating women 7) history of severe drug allergy 8) psychiatric disease

Related Information

Contact

public contact
Name Young Hak Kim
Address Japan
Telephone 075-751-3830
E-mail
Affiliation Graduate School of Medicine, Kyoto University Department of Respiratory Medicine
scientific contact
Name Young Hak Kim
Address 54 Shogoin-Kawaharacho, Sakyo-Ku, Kyoto 606-8507, Japan Japan
Telephone
E-mail
Affiliation Graduate School of Medicine, Kyoto University Department of Respiratory Medicine